anastrazolehttp://www.unboundmedicine.com/medline/ebm/research/anastrazoleUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia.http://www.unboundmedicine.com/medline/ebm/record/19887477/full_citation/Randomized_Biomarker_Trial_of_Anastrozole_or_Low_Dose_Tamoxifen_or_Their_Combination_in_Subjects_with_Breast_Intraepithelial_Neoplasia_Bonanni B, Serrano D, Gandini S, et al. 
Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 3.
Abstract | Full CitationImpact of aromatase inhibitors on bone health in breast cancer patients.http://www.unboundmedicine.com/medline/ebm/record/19833206/full_citation/Impact_of_aromatase_inhibitors_on_bone_health_in_breast_cancer_patients_Geisler J, Lønning PE 
Impact of aromatase inhibitors on bone health in breast cancer patients. [JOURNAL ARTICLE]
J Steroid Biochem Mol Biol 2009 Oct 12.
Abstract | Full CitationPotential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.http://www.unboundmedicine.com/medline/ebm/record/19821643/full_citation/Potential_role_of_UGT_pharmacogenetics_in_cancer_treatment_and_prevention:_focus_on_tamoxifen_and_aromatase_inhibitors_Lazarus P, Sun D 
Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors. [JOURNAL ARTICLE]
Drug Metab Rev 2009 Oct 12.
Abstract | Full Citation | Find Related Articles Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.http://www.unboundmedicine.com/medline/ebm/record/19821307/full_citation/Aromatase_inhibitors_for_treatment_of_advanced_breast_cancer_in_postmenopausal_women_Gibson L, Lawrence D, Dawson C, et al. 
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. [Journal Article]
Cochrane Database Syst Rev 2009; (4):CD003370.
Abstract | Full Citation | Find Related Articles Effects of Aromatase Inhibition on Bone Mineral Density and Bone Turnover in Older Men with Low Testosterone Levels.http://www.unboundmedicine.com/medline/ebm/record/19820017/full_citation/Effects_of_Aromatase_Inhibition_on_Bone_Mineral_Density_and_Bone_Turnover_in_Older_Men_with_Low_Testosterone_Levels_Burnett-Bowie SA, McKay EA, Lee H, et al. 
Effects of Aromatase Inhibition on Bone Mineral Density and Bone Turnover in Older Men with Low Testosterone Levels. [JOURNAL ARTICLE]
J Clin Endocrinol Metab 2009 Oct 9.
Abstract | Full Citation | Find Related Articles Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.http://www.unboundmedicine.com/medline/ebm/record/19819437/full_citation/Effect_of_aromatase_inhibitors_on_ectopic_endometrial_growth_and_peritoneal_environment_in_a_mouse_model_of_endometriosis_Bilotas M, Meresman G, Stella I, et al. 
Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis. [JOURNAL ARTICLE]
Fertil Steril 2009 Oct 9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.http://www.unboundmedicine.com/medline/ebm/record/19794821/full_citation/Anastrozole_Use_in_Early_Stage_Breast_Cancer_of_Post_Menopausal_Women_Milani M, Jha G, Potter DA 
Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women. [JOURNAL ARTICLE]
Clin Med Ther 2009 Mar 31.:141-156.
Abstract | Full CitationTrastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study.http://www.unboundmedicine.com/medline/ebm/record/19786670/full_citation/Trastuzumab_Plus_Anastrozole_Versus_Anastrozole_Alone_for_the_Treatment_of_Postmenopausal_Women_With_Human_Epidermal_Growth_Factor_Receptor_2_Positive_Hormone_Receptor_Positive_Metastatic_Breast_Cancer:_Results_From_the_Randomized_Phase_III_TAnDEM_Study_Kaufman B, Mackey JR, Clemens MR, et al. 
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study. [JOURNAL ARTICLE]
J Clin Oncol 2009 Sep 28.
Abstract | Full Citation | Find Related Articles Effect of testosterone on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.http://www.unboundmedicine.com/medline/ebm/record/19778611/full_citation/Effect_of_testosterone_on_E1S_sulfatase_activity_in_non_malignant_and_cancerous_breast_cells_in_vitro_Götte M, Kalkhake K, Ploeger S, et al. 
Effect of testosterone on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro. [JOURNAL ARTICLE]
J Steroid Biochem Mol Biol 2009 Sep 21.
Abstract | Full Citation | Find Related Articles A case of uterine tumour resembling ovarian sex cord tumour responding to second-line, single agent anastrazole.http://www.unboundmedicine.com/medline/ebm/record/19769683/full_citation/A_case_of_uterine_tumour_resembling_ovarian_sex_cord_tumour_responding_to_second_line_single_agent_anastrazole_Blinman P, Tattersall MH 
A case of uterine tumour resembling ovarian sex cord tumour responding to second-line, single agent anastrazole. [Journal Article]
Intern Med J 2009 Sep; 39(9):617-9.
Abstract | Full Citation | Find Related Articles